Dysfunction of innate immunity and associated pathology in neonates

Indian Journal of Pediatrics

Volumn 74, Issue 2, 2007, Pages 185-191

  Petrova, Anna ^a   Mehta, Rajeev ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Complement; Innate immunity; Neonates; Neutrophils

Indexed keywords

PROTEIN; COMPLEMENT;

AUTHOR; COMPLEMENT SYSTEM; CONFERENCE PAPER; GESTATIONAL AGE; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFLAMMATION; INFORMATION; INNATE IMMUNITY; KNOWLEDGE; MOTHER; MOTHER FETUS RELATIONSHIP; NEUTROPHIL; NEWBORN PERIOD; NONHUMAN; PATHOLOGY; RESEARCH; TISSUE INJURY; FEMALE; IMMUNOLOGY; MALE; NEWBORN; PASSIVE IMMUNIZATION; PHYSIOLOGY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNITY, NATURAL; INFANT, NEWBORN; MALE; NEUTROPHILS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33947732136     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0013-2     Document Type: Conference Paper

References (117)

1. Marodi L. Neonatal innate immunity to infectious agents. Infect Immun 2006; 74: 1999-2006.
2. Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001; 99: 7-17.
3. Zilow EP, Hauck W, Linderkamp O, Zilow G. Alternative pathway activation of the complement system in preterm infants with early onset infection. Pediatr Res 1997; 41: 334-339.
4. Mathison RD, Befus AD, Davison JS, Woodman RC. Modulation of neutrophil function by the tripeptide feG. BMC Immunol 2003; 4: 3-17.
5. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003; 102: 2660-2669.
6. Segal AW. Structure of the NADPH-oxidase: membrane components. Immunodeficiency 1993; 4: 167-179.
7. Cowell RM, Plane JM, Silverstein FS. Complement Activation Contributes to Hypoxic-Ischemic Brain Injury in Neonatal Rats. J Neuroscie 2003; 23: 9459-9468.
8. Palis J, Yoder MC. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp Hematol 2001; 29: 927-936.
9. Tavian M, Robin C, Coulombel L, Peault B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 2001; 15: 487-495.
10. Migliaccio G, Migliaccio AR, Petti S, Mavilio F, Russo G, Lazzaro D, Testa U, Marinucci M, Peschle C. Human embryonic hemopoiesis: kinetics of progenitors and precursors underlying the yolk sac-liver transition. J Clin Invest 1986; 78: 51-60.
11. Robin C, Ottersbach K, de Bruijn M, Ma X, van der Horn K, Dzierzak E. Developmental origins of hematopoietic stem cells. Oncol Res 2003; 13: 315-321.
12. Palis J, Yoder MC. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp Hematol 2001; 29: 927-936.
13. Kelemen E, Calvo W, Fleidner TM. Atlas of human hemopoietic development, New York: Springer-Verlag; 1979
14. Koenig JM, Christensen RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med 1989; 321: 557-562.
15. Koenig JM, Christensen RD. The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 165: 467-473.
16. Tsao PN, Teng RJ, Tang JR, Yau KI. Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension. J Pediatr 1999; 135: 56-59.
17. Kocherlakota P, La Gamma EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998; 102: 1107-1011.
18. Speer CP, Johnston RB Jr. Neutrophil function in newborn infants. In Pollin RA, Fox WW, eds. Fetal and Neonatal Physiology. Philadelphia; Pa: WB Saunders; 1998; 1954-1960.
19. Koenig JM, Chegini N. Enhanced expression of Fas-associated proteins in decidual and trophoblastic tissues in pregnancy-induced hypertension. Am J Reprod Immunol 2000; 44: 347-349.
20. Kuntz TB, Christensen RD, Stegner J, Duff P, Koenig JM. Fas and Fas ligand expression in maternal blood and in umbilical cord blood in preeclampsia. Pediatr Res 2001; 50: 743-749.
21. Bux J, Jung KD, Kauth T, Mueller-Eckhardt C. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfus Med 1992; 2: 143-149.
22. Rodwell RL, Gray PH, Taylor KM, Minchinton R. Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia. Arch Dis Child Fetal Neonatal Ed. 1996; 75: F57-58.
23. Lapolla A, Sanzari MC, Zancanaro F, Masin M, Guerriero A, Piva I, Toniato R, Erle G, Plebani M, Fedele D. A study on lymphocyte subpopulation in diabetic mothers at delivery and in their newborn. Diabetes Nutr Metab 1999; 12: 394-399.
24. Mohandes AE, Touraine JL, Osman M, Salle B. Neutrophil chemotaxis in infants of diabetic mothers and in preterms at birth. J Clin Lab Immunol 1982; 8: 117-120.
25. Mehta R, Petrova A. Neutrophil Function in Neonates Born to Gestational Diabetic Mothers. J Perinatol 2005; 25: 178-181.
26. Mehta R, Petrova A. Intrapartum Magnesium Sulfate Exposure Attenuates Neutrophil Function in Preterm Neonates. Biol Neonate 2006; 89: 99-103.
27. Mehta R, Petrova A. Intrauterine neutrophil activation is associated with pulmonary haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91:F415-418.
28. Richani K, Soto E, Romero R, Espinosa J, Chaiworapongsa T, Nien JK, Edwin S, Kim YM, Hong JS, Mazor M. Normal Pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005; 17: 239-245.
29. Jarvis JN, Moore HT, Fine N, Berry SM. Expression of complement regulatory proteins on fetal blood cells in utero. Biol Neonate 1996; 69: 225-229.
30. Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 1993; 151: 1562-1570.
31. Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, Espinola R, Xiapwei LE, Mao D, Vialpando CG, Salmon JE. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 2: 211-220.
32. Soto E, Romero R, Richani K, Espinoza J, Nien JK, Chaiworapongsa T, Santolaya-Forgras J, Edwin SS, Mazor M. Anaphylatoxins in preterm and term labor. J Perinatal Med 2005; 33: 306-313.
33. Elimian A, Figueroa R, Canterino J, Verma U, Aguero-Rosenfeld M, Tejani N. Amniotic fluid complement C3 as a marker of intra-amniotic infection. Obstet Gynecol 1998; 92: 72-76.
34. Tashima LS, Millar LK, Bryant-Greenwood GD. Genes upregulated in human fetal membranes by infection or labor. Obstet Gynecol 1999; 94: 441-449.
35. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease: I. Reference values for neutrophilic cells. J Pediatr 1979; 95: 89-99.
36. Geissler K, Geissler W, Hinterberger W, Lechner K, Wurnig P. Circulating committed and pluripotent haemopoietic progenitor cells, in infants. Acta Haematol 1986;75:18-22.
37. Christensen RD, Hill HR, Rothstein G. Granulocytic stem cell (CFUc) proliferation in experimental group B streptococcal sepsis. Pediatr Res 1983; 17: 278-280.
38. Koenig JM, Luttge B, Benson NA, Christensen RD. Cell cycle status of CD34 + cells in human fetal bone marrow. Early Hum Dev 2001; 65: 159-163.
39. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 1994; 94: 76-82.
40. Crockett M. Physiology of the neonatal immune system. J Obstetr Gynecol Neonatal Nur 1995; 24: 627-634.
41. Sonntag J, Brandenburg U. Polzehl D, Strauss E, Vogel E. Dudenhausen JW, Obladen M. Complement system in healthy term newborns: reference values in umbilical cord blood. Pediatr Dev Pathol 1998; 1: 131-135.
42. Huffaker J, Witkin SS, Cutler L, Druzin ML, Ledger WJ. Total complement activity in maternal sera, amniotic fluids and cord sera in women with premature labor, preterm rupture of membranes or chorioamnionitis. Surg Gynecol Obstet 1989; 168: 397-401.
43. Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol 1998; 22: 2-14.
44. Davies J, Turner M, Klein N. The role of the collectin system in pulmonary defense. Paediatr Respir Rev 2001; 2: 70-75.
45. Watford W, Wright JR, Hester CG, Jiang H, Frank MM. Surfactant protein A regulates complement activation. J Immunol 2001; 167: 6593-6600.
46. Petrova A, Hanna N, Mehta R. Gestational age related maternal-fetal- neonatal humoral immunity. J Applied Research 2004; 4: 44-49.
47. Zilow EP, Hauck W, Linderkamp O, Zilow G. Alternative pathway activation of the complement system in preterm infants with early onset infection. Pediatr Res 1997; 41: 334-339.
48. Miyano A, Nakayama M, Fujita T, Kitajima H, Imai S, Shimizu A. Complement activation in fetuses: assessment by the levels of complement components and split products incord blood. Diagn Immunol 1987; 5: 320-327.
49. Petrova A, Mehta R. Innate Immunity in Mothers and their Newborn Infants during Preterm Premature Rupture of Membranes. J Applied Research 2005; 5: 282-288.
50. Christensen RD. Developmental changes in pluripotent hematopoietic progenitors. Early Hum Dev 1988; 16: 195-205.
51. Mease AD. Tissue neutropenia: the newborn neutrophil in perspective. J Perinatol 1990; 10: 55-59.
52. Cairo MS, Rucker R, Bennetts GA, Hicks D, Worcester C, Amlie R, Johnson S, Katz J. Improved survival of newborns receiving leukocyte transfusions for sepsis. Pediatrics 1984; 74: 887-892.
53. Christensen RD, Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 1980; 96: 316-318.
54. Baley JE, Stork EK, Warkentin PI, Shurin SB. Neonatal neutropenia. Am J Dis Child 1988; 142: 1161-1166.
55. Anderson DC, Abbassi O, Kishimoto TK, Koenig JM, McIntire LV, Smith CW. Diminished lectin-, epidermal growth factor-, complement binding domain-cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells in vitro. J Immunol 1991; 146: 3372-3379.
56. Abughali N, Berger M, Tosi MF. Deficient total cell content of CR3 (C11b) in neonatal neutrophils. Blood 1994; 83: 1086-1092.
57. Ramamoorthy C, Kovarik WD, Winn RK, Harlan JM, Sharar SR. Neutrophil adhesion molecule expression is comparable in perinatal rabbits and humans. Anesthesiology 1997; 86: 420-427.
58. Christensen RD. Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol 1989; 11: 215-223.
59. al-Mulla ZS, Christensen RD. Neutropenia in the neonate. Clin Perinatol 1995;22: 711-739.
60. Carr R. Neutrophil production and function in newborn infants. Br J Haematol 2000; 110: 18-28.
61. Anderson DC. Neonatal neutrophil dysfunction. Am J Pediatr Hematol Oncol 1989; 11: 224-226.
62. Christensen RD. Granulocytopoiesis in the neonate and fetus. Trans Med Rev 1990; 4: 8-13.
63. Kapur R, Yoder MC, Polin RA. Developmental immunology. In Fanaroff AA, Martin RJ, eds. Neonatal-perinatal medicine St. Louis: Mosby; 2001. p. 676-706.
64. Lewis DB, Wilson CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: W.B. Saunders, 2001; 25-138.
65. Kim SK, Keeney SE, Alpard SK, Schmalstieg FC. Comparison of L-selectin and CD11b on neutrophils of adults and neonates during the first month of life. Pediatr Res 2003; 53: 132-136.
66. Graf JM, Smith CW, Mariscalco MM. Contribution of LFA-1 and Mac-1 to CD18-dependent neutrophil emigration in a neonatal rabbit model. J Appl Physiol 1996; 80: 1984-1992.
67. Anderson DC, Freeman KL, Heerdt B, Hughes BJ, Jack RM, Smith CW. Abnormal stimulated adherence of neonatal granulocytes: impaired induction of surface Mac-1 by chemotactic factors or secretagogues. Blood 1987;70: 740-750.
68. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987; 38: 175-194.
69. Koenig JM, Baron S, Luo D, Benson NA, Deisseroth AB. L-selectin expression enhances clonogenesis of CD34 + cord blood progenitors. Pediatr Res 1999; 45: 867-870.
70. Rebuck N, Gibson A, Finn A. Neutrophil adhesion molecules in term and premature infants: normal or enhanced leucocyte integrins but defective L-selectin expression and shedding. Clin Exp Immunol 1995; 101: 183-189.
71. Koenig JM, Simon J, Anderson DC, Smith E, Smith CW. Diminished soluble and total cellular L-selectin in cord blood is associated with its impaired shedding from activated neutrophils. Pediatr Res 1996; 39: 616-621.
72. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease: I. Reference values for neutrophilic cells. J Pediatr 1979; 95: 89-98.
73. Kim SK, Keeney SE, Alpard SK, Schmalstieg FC. Comparison of L-selectin and CD11b on neutrophils of adults and neonates during the first month of life. Pediatr Res 2003; 53: 132-136.
74. Weinberger B, Laskin DL, Mariano TM, Sunil VR, DeCoste CJ, Heck DE, Gardner CR, Laskin JD. Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants. J Leukoc Biol 2001; 70: 969-976.
75. Harris MC, Shalit M, Southwick FS. Diminished actin polymerization by neutrophils from newborn infants. Pediatr Res 1993; 33: 27-31.
76. Meade VM, Barese CN, Kim C, Njinimbam CG, Marchal CC, Ingram DA, Clapp DW, Dinauer MC, Yoder MC. Rac2 concentrations in umbilical cord neutrophils. Biol Neonate 2006; 90: 156-159.
77. Glasner A, Egger G, Winter R. Impaired whole-blood polymorphonuclear leukocyte migration as a possible predictive marker for infections in preterm premature rupture of membranes. Infect Dis Obstet Gynecol 2001; 9: 227-232.
78. Baker CJ, Rench MA, Noya FJ, Garcia-Prats JA. Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. The Neonatal IVIG Study Group. Rev Infect Dis 1990; 12: S463-468.
79. Dyke MP, Forsyth KD. Plasma fibronectin levels in extremely preterm infants in the first 8 weeks of life. J Paediatr Child Health 1994; 30: 36-39.
80. Kallman J, Schollin J, Schalen C, Erlandsson A, Kihlstrom E. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1998; 78: F46-50.
81. Summerfield JA, Sumiya M, Levin M et al. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314: 1229-1232.
82. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989; 2: 1236-1239.
83. Lewis DB, Wilson CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant Philadelphia: W.B. Saunders, 2001; 25-138.
84. Hill HR. Biochemical, structural and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 1987; 22: 375-382.
85. Kjeldsen L, Sengelov H, Lollike K, Borregaard N. Granules and secretory vesicles in human neonatal neutrophils. Pediatr Res 1996; 40: 120-129.
86. Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 1999; 104: 1327-1333.
87. Clifford CB, Slauson DO, Neilsen NR, Suyemoto MM, Zwahlen RD, Schlafer DH. Ontogeny of inflammatory cell responsiveness. Inflammation 1989; 13: 221-231
88. Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ. Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med 1981; 95: 293-301.
89. Lakshman R, Finn A. Neutrophil disorders and their management. Clin Pathol 2001; 54: 7-19.
90. Molloy EJ, O'Neill AJ, Doyle BT, Grantham JJ, Taylor CT, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, Watson RW. Effects of heat shock and hypoxia on neonatal neutrophil lipopolysaccharide responses: altered apoptosis, Toll-like receptor-4 and CD11b expression compared with adults. Biol Neonate 2006; 90: 34-39.
91. Oei J, Lui K, Wang H, Henry R. Decreased neutrophil apoptosis in tracheal fluids of preterm infants at risk of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2003; 88: F245-249.
92. Kotecha S, Mildner RJ, Prince LR, Vyas JR, Currie AE, Lawson RA, Whyte MK. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 2003; 58: 961-967.
93. Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001; 99: 7-17.
94. Haslett C. Granulocyte apoptosis and inflammatory disease. Br Med Bull 1997; 53: 669-683.
95. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160: S5-S11.
96. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001; 79: 205-209.
97. Dransfield I, Stocks SC, Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood 1995; 85: 3264-3673.
98. Allgaier B, Shi M, Luo D, Koenig JM. Spontaneous and Fasmediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils. J Leukoc Biol 1998; 64: 331-336.
99. Luo D, Schowengerdt Jr KO, Stegner JJ, May Jr WS, Koenig JM. Decreased functional caspase-3 expression in umbilical cord blood neutrophils is linked to delayed apoptosis. Pediatr Res 2003; 53: 859-864.
100. Koenig JM, Stegner JJ, Schmeck AC, Saxonhouse MA, Kenigsberg LE. Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr Res 2005; 57: 424-429.
101. Stegner JJ, Schmeck A, Kenigsberg L, Saxonhouse M, Koenig JM. Umbilical cord blood neutrophils with prolonged survival retain their capacity to elaborate reactive oxygen intermediates. Pediatr Res 2004; 55: 390A.
102. Yasumatsu R, Altiok O, Benarafa C, Yasumatsu C, Bingol-Karakoc G, Remold-O'Donnell E, Cataltepe S. SERPINB1 upregulation is associated with in vivo complex formation with neutrophil elastase and cathepsin G in a baboon model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2006; 291: L619-627.
103. Castellheim A, Pharo A, Fung M, Saugstad OD, Mollnes TE. Complement C5a is a key mediator of meconium-induced neutrophil activation. Pediatr Res 2005; 57: 242-247.
104. Lassiter HA. Complement factor 9 deficiency in serum of human neonates. J Infect Dis 1992; 166: 53-57.
105. Hogasen AK, Overlie I, Hansen TW, Abrahamsen TG. Finne PH, Hogasen K. The analysis of the complement activation product SC5b9 is applicable in neonates in spite of their profound C9 deficiency. J Perinat Med 2000; 28: 39-48.
106. Turker G, Koksal N. Complement 4 levels as early predictors of poor response to surfactant therapy in respiratory distress syndrome. Am J Perinatol 2005; 22: 149-154.
107. Watford WT, Wright JR, Hester CG, Jiang H, Frank MM. Surfactant protein A regulates complement activation. J Immunol 2001; 167: 6593-6600.
108. Lindenskov PH, Castellheim A, Aamodt G, Saugstad OD. Mollnes TE. Complement activation reflects severity of meconium aspiration syndrome in newborn pigs. Pediatr Res 2004; 56: 810-817.
109. Miyano A, Kitajima H, Fujiwara F, Nakayama M, Fujita T, Fujimura M, Takeuchi T, Shimizu A. Complement function and the synthesis of lung surfactant may be a regulation which preterm infants have in common. Complement Inflamm 1991; 8: 320-327.
110. Hecke F, Hoehn T, Strauss E, Obladen M, Sonntag J. In-vitro activation of complement system by lactic acidosis in newborn and adults. Mediators Inflamm 2001; 10: 27-31.
111. Sonntag J, Wagner MH, Strauss E, Obladen M. Complement and contact activation in term neonates after fetal acidosis. Arch Dis Child Fetal Neonatal Ed 1998; 78: F125-F128.
112. Frank MM, Miletic VD, Jiang H. Immunoglobulin in the control of complement action. Immunol Res 2000; 22: 137-146.
113. Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection. Pediatr Res 1993; 34: 199-203.
114. Lassiter A. The role of complement in neonatal hypoxicischemic cerebral injury. Clin Perinatol 2004; 31: 117-127.
115. Schultz SJ, Aly H, Hasanen BM, Khashaba MT, Lear SC, Bendon RW, Gordon LE, Feldholff PW, Lassiter HA. Complement component 9 activation, consumption and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants. Neurosci Lett 2005; 378: 1-6.
116. Miletic VD, Frank MM. Complement-immunoglobulin interactions. Curr Opin Immunol 1995; 7: 41-47.
117. Landor M. Maternal-fetal transfer of immunoglobulins. Ann Immunol 1995; 74: 279-283.